- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03014817
Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis Trial
Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis. A Randomized, Double Blind, Multicenter Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Electrocautery is traditionally the method of choice for tissue dissection in laparoscopic cholecystectomy. As an alternative to electrocautery, the ultrasonically activated scalpel has proven to be an effective and safe instrument for the facilitation of dissection and to minimize blood loss in both open and laparoscopic surgery. Whereas electrocautery coagulates by burning at temperatures higher than 150ºC, the ultrasonic scalpel transforms the electric power into mechanical longitudinal vibration of the working part of the instrument by a piezoelectrical transducer. Accordingly, the former technique limits the heating- thermal necrosis effect on the tissue to the area just adjacent to the cutting line.
Since the relative-potential benefit of the ultrasonic scalpel is high in technically demanding surgery, the advantage may not be as pronounced in routine laparoscopic gallstone surgery, which can usually be done more uneventfully whichever equipment is used. Laparoscopic cholecystectomy for acute cholecystitis is, however, more demanding connected with longer operative time, more postoperative complications, greater risk of conversion to open cholecystectomy and longer postoperative stay. In addition, we know that operations for acute cholecystitis are associated with a higher risk for severe complications such as bile duct injury. The potential benefit from using the ultrasonic scalpel is thus even greater when doing surgery for cholecystitis.
In addition to this there are numerous important aspects on the safety in the implementation of the emergency cholecystectomy. Traditionally, most surgeons have chosen to operate these patients with laparoscopic technique, with the use of a so-called electrocautery hook, which usually allows tissue division with minimal blood loss. Further improvements in the dissection technique followed the introduction of ultrasonic tissue coagulation. This technique offers the option of performing these operations with even less blood loss, a more gentle handling of the inflamed tissue and a sealing of the tissue sections while the tissue is divided. Accordingly this ultrasonic tissue coagulation technique can theoretically be of significant advantage not the least when dividing acutely inflamed tissue like in acute cholecystitis with particular relevance for the dissection of the gallbladder from the liver bed, where bleeding and bile leakage often occurs. Moreover if the surgeon instead chooses to dissect the gallbladder from the doom and downwards, to the part that contains the cystic duct and cystic artery (Calots triangle), unique options can be offered to not only simplify the operation but also make it safer. This latter technique is called "fundus first".
The present study aims at analyzing whether ultrasonic tissue coagulation dissection technique combined with "fundus first" approach offers a smoother per and postoperative course in acute cholecystectomy patients as compared to the traditional way of performing the operation. Due to the lower risk of bleeding and better anatomical overview, the technique may also reduce the risk of having to convert the procedure for laparoscopic cholecystectomy to open cholecystectomy.
The study is performed as a double-blinded study on patients undergoing laparoscopic surgery for acute cholecystitis. Patients included in the study are randomized to surgery with either the traditional electrocautery based technique or ultrasonic scalpel based dissection with the "fundus first" approach.
The choice of dissection approach is determined by the randomization procedure, whether it is done from the triangle of Callot + electrocautery and upwards or from the gallbladder fundus and downwards by the use of the ultrasonic scalpel. Peroperative cholangiography is done routinely. The cystic duct is closed with a clip, not with the ultrasonic scalpel.
One month after surgery the patient is contacted by a telephone. In cases the questionnaires have not been returned yet, the patient is reminded about this. At the phone call the exact number of days of sick leave postoperatively and any adverse events occurring after discharge are recorded.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 14186
- Karolinska University Hospital, Center for Digestive Diseases
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Emergency laparoscopic cholecystectomy performed for cholecystitis
- American Society of Anesthesiologists (ASA) score I-III
Exclusion Criteria:
- Patients unable to express themselves in Swedish
- Pregnancy
- Previous open surgery in the upper abdomen
- American Society of Anesthesiologists (ASA) score >III
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Ultrasonically activated scalpel
Dissection with ultrasonically activated scalpel.
Direction of dissection undecided but by experience most naturally fundus first.
|
Dissection with ultrasonically activated scalpel
|
|
Active Comparator: Electrocautery
Dissection with electrocautery.
Direction of dissection undecided but by experience most naturally cystic duct first.
|
Dissection with electrocautery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative complications
Time Frame: 30 days
|
Postoperative complications registered according to Clavien-Dindo
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative time
Time Frame: 3 hours
|
Time required to complete surgery
|
3 hours
|
|
Level of technical complexity
Time Frame: 3 hours
|
Level of technical complexity of the procedure as assessed by the surgeon
|
3 hours
|
|
Technical performance
Time Frame: 3 hours
|
Perioperative technical performance assessed by an independent observer
|
3 hours
|
|
Postoperative stay
Time Frame: 14 days
|
Time from surgery to duscharge
|
14 days
|
|
Sick leave
Time Frame: 30 days
|
Time from surgery to return to work
|
30 days
|
|
Conversion rate
Time Frame: 3 hours
|
Conversion from laparoscopic to open cholecystyectomy
|
3 hours
|
|
Postoperative pain
Time Frame: 7 days
|
Daily assessments of pain on a visual analogue scale
|
7 days
|
|
Postoperative inflammatory activity
Time Frame: 7 days
|
Daily measurements of c-reactive protein and leukocyte particle concentration
|
7 days
|
|
Conversion rate
Time Frame: 3 hours
|
Number of procedures converted to open cholecystectomy
|
3 hours
|
|
Direct and indirect medical costs
Time Frame: 30 days
|
Analysis of health economics
|
30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gabriel Sandblom, Assoc Prof, Karolinska Institutet
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ultrasonic scalpel trial
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholecystitis, Acute
-
Hospital General de Chihuahua - Dr. Salvador Zubirán...CompletedAcute Cholecystitis | Acute Cholecystitis With ObstructionMexico
-
Konya Meram State HospitalCompleted
-
Azienda Ospedaliero, Universitaria PisanaCompletedAcute CholecystitisItaly
-
University Hospital, GhentCompletedUncomplicated Acute CholecystitisBelgium, Qatar
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingAcute Calculous Cholecystitis Candidate to Early CholecystectomyItaly
-
IRCCS Policlinico S. MatteoCompleted
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingHigh-risk Patients With Acute Calculous Cholecystitis (ACC)Italy
-
Aichi Medical UniversityRecruitingAcute Calculous CholecystitisJapan
-
The University of Texas Health Science Center at...CompletedAcute Cholecystitis | Chronic CholecystitisUnited States
-
Istituto Clinico Humanitas Mater DominiRecruiting
Clinical Trials on Ultrasonically activated scalpel
-
Seoul National University HospitalJohnson & Johnson Medical CompaniesCompletedGastric CancerKorea, Republic of
-
University Hospital, GhentUniversity GhentCompletedPost-operative PainBelgium
-
Barretos Cancer HospitalCompletedWound Infection | CicatrizationBrazil
-
Barretos Cancer HospitalCompletedComplication, PostoperativeBrazil
-
Johannes Gutenberg University MainzCompletedObesity | Difficult Airway | CricothyroidotomyGermany
-
Center of Endourology "Endocenter"Not yet recruitingHemorrhoids | Open HemorrhoidectomyRussian Federation
-
Medtronic Surgical TechnologiesCompleted
-
Medtronic Surgical TechnologiesTerminatedBreast CancerUnited States
-
University of CalgaryCompleted
-
Unity Health TorontoUnknownSurgery | Pituitary Tumor | Olfactory Nerve InjuriesCanada